Evidence map›Paper›PMID 41589137›Full record

ArticleJournal of clinical biochemistry and nutrition2026

Carotenoid bioavailability in humans reflects the mammalian nocturnal bottleneck: a position paper.

Junji Terao

Abstract read
In one paragraph

Article in Journal of clinical biochemistry and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Junji TeraoFaculty of Medicine, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recommended levels of dietary carotenoids remain uncertain, although their health benefits have gained renewed interest. One reason is that humans have a unique bioavailability of carotenoids compared to other mammals, which is not well understood. This position paper suggests that humans' bioavailability of dietary carotenoids reflects the mammalian nocturnal bottleneck-a period when the ancestors of modern mammals became nocturnal during the Mesozoic era to avoid predatory dinosaurs. The roles of carotenoids are closely linked to evolutionary processes involving light and vision. Vertebrates developed advanced color vision by using specific xanthophylls in their photoreceptor cells. In contrast, mammals' color vision declined due to their nocturnal lifestyle. Primates later returned to daytime activity and accumulated two xanthophylls, lutein and zeaxanthin, from their diet, in the macular lutea of the eyes, to protect color vision. Additionally, humans uniquely store β-carotene and lycopene in exposed skin. Throughout primate evolution, humans' ability to accumulate dietary carotenoids shifted from xanthophylls toward less polar carotenoids, including β-carotene and lycopene, unlike the high selectivity of xanthophylls observed in birds. Overall, carotenoid deposition in human tissues is not highly specialized, likely due to remnants of the mammalian nocturnal bottleneck. We should consider this when evaluating recommended carotenoid intake.

Indexed as

biological evolutioncarotenoidscolor visionmacular pigmentmammalian nocturnal bottleneck

Identifiers

PMID41589137
PMCPMC12832137

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.